# Dose Finding Study of PB127 Ultrasound Contrast Agent in Healthy Volunteers and Patients With Coronary Artery Disease

> **NCT00584818** · PHASE2 · COMPLETED · sponsor: **Point Biomedical** · enrollment: 205 (actual)

## Conditions studied

- Healthy
- Coronary Artery Disease

## Interventions

- **DRUG:** PB127 for Injectable Suspension

## Key facts

- **NCT ID:** NCT00584818
- **Lead sponsor:** Point Biomedical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 205 (ACTUAL)
- **Last updated:** 2008-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00584818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00584818, "Dose Finding Study of PB127 Ultrasound Contrast Agent in Healthy Volunteers and Patients With Coronary Artery Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00584818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*